Publication date	Issuer	Person discharging managerial responsibilities	Position	Closely associated	Nature of transaction	Instrument name	Intrument type	ISIN	Transaction date	Volume	Unit	Price	Currency	Status	Details
06/04/2018	Xbrane Biopharma AB	PETER EDMAN	Styrelseledamot/suppleant		Acquisition	Aktier		SE0007789409	06/04/2018	1,500	Quantity	61.04	SEK		Notification
06/04/2018	Xbrane Biopharma AB	David Vikström	Forskningschef		Acquisition	Teckningsoption 2018/2022			05/04/2018	24,000	Quantity	4.1775	SEK		Notification
05/04/2018	Xbrane Biopharma AB	Alessandro Sidoli	Board member		Acquisition	Shares		SE0007789409	05/04/2018	2,000	Quantity	61.04	SEK		Notification
05/04/2018	Xbrane Biopharma AB	Alessandro Sidoli	Board member		Acquisition	Teckningsoption 2018/2021-2			05/04/2018	3,000	Quantity	5.8797	SEK		Notification
05/04/2018	Xbrane Biopharma AB	Maris Hartmanis	Styrelseledamot/suppleant		Acquisition	Teckningsoption 2018/2021-2			05/04/2018	2,250	Quantity	5.8797	SEK		Notification
05/04/2018	Xbrane Biopharma AB	Siavash Bashiri	COO & Head of Biosimilars,Vice VD		Acquisition	Teckningsoption 2018/2022			05/04/2018	7,000	Quantity	4.1775	SEK		Notification
05/04/2018	Xbrane Biopharma AB	Maris Hartmanis	Styrelseledamot/suppleant		Acquisition	Aktier		SE0007789409	05/04/2018	1,500	Quantity	61.04	SEK		Notification
05/04/2018	Xbrane Biopharma AB	Susanna Helgesen	Ekonomi/finanschef		Acquisition	Teckningsoption 2018/2022			05/04/2018	24,000	Quantity	4.1775	SEK		Notification
24/01/2018	Xbrane Biopharma AB (publ.)	David Vikström	CTO		Acquisition	Xbrane Biopharma AB		SE0007789409	23/01/2018	370	Quantity	79.66	SEK		Notification
23/01/2018	Xbrane Biopharma AB (publ)	Siavash Bashiri	COO & Head of Biosimilars		Acquisition	Xbrane		SE0007789409	23/01/2018	289	Quantity	79.60	SEK		Notification